The page is the record's research on the issuer — no analyst, no rating, no view. # Fuji Pharma Co.,Ltd. (Prime Market: 4554) — research page As of 2026-11-06 · jp-cm-kg · record version 1 ## Identity and listing Fuji Pharma Co.,Ltd. is listed on the Prime Market under ticker 4554, ISIN JP3816200004 and LEI 529900L1XVCEHVKHAM60. Its security type is Corporate, its segment is not on the record, its sector is 3250 Pharmaceutical and its jurisdiction is Japan (EDINET domestic filer). Its listing status is listed, not halted. ## The disclosure read The record holds 6 filings in the twelve months to 2026-11-06, on 3 filing days. Of the filings, 1 is ad hoc, 3 are regulatory filings and 2 are results. The median gap between filing days is 73.0 days. The latest filing is dated 2026-05-13, a regulatory filing, 177 days before the record date. The Prime Market median is 29.0 days of cadence gap, 10 filings and 70.0 days of latency across 1557 issuers. The 3250 Pharmaceutical median is 49.5 days of cadence gap, 8.0 filings and 85.0 days of latency across 80 issuers. ## Auditor The auditor of record is 有限責任 あずさ監査法人. Its location is not on the record. Auditor changes are not on the record, as this register has no lifecycle type map yet. ## Events and halts Listing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag is listed, not halted. ## Orderability For the client category Qualified Institutional Investors, the signal is not determinable, because the rule states a product scope and the subject's record carries no instrument class to place within it. The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, and the chapter is as of 2026-11-04. ## Coverage The issuer's investor-relations page names 3 research houses: Tokai Tokyo Intelligence Laboratory Co., Ltd., Toyo Securities Co., Ltd. and Mizuho Securities Co., Ltd. ## Open research The record holds 1 openly published research note: FISCO Ltd., dated 2026-01-20. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The market's vintage is not sealed. No issuer years are sealed, and the market's earliest sealed date and the live record start date are not on the record. ## Sources 11 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx (identity.exchange) - https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin) - https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip (identity.jurisdiction) - https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei) - https://mcp.jp-cm-kg.ai/events/TSE-PRIME/4554 (the disclosure lines) - https://www.jpx.co.jp/markets/equities/suspended/index.html (the halt flag) - https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100XAU2 (the auditor) - https://mcp.jp-cm-kg.ai/book/aio.json (the orderability chapter) - https://www.fujipharma.jp/english/ir/stock/ (coverage) - https://www.fujipharma.jp/english/__upload/EN_sr_report_202601.pdf (open research) - https://mcp.jp-cm-kg.ai/record/TSE-PRIME/4554 (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/jp/TSE-PRIME/4554 · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp